Corcept Therapeutics | Zinsaufwendungen Für Schuld

Created with Highcharts 10.1.0Chart context menu-1.94M-1.47M01.47M2.94M4.41M5.88M6.49M
2019Q3Q3Q32024


Interest Expense On Debt Veränderung Datum
Alaunos Therapeutics USD 0 0 2023-12
ANI Pharmaceuticals USD 2.33M 2.33M 2024-09
Ardelyx USD 3.97M 610K 2024-12
Aurora Cannabis CAD 1.29M 768K 2024-12
BioMarin Pharmaceutical USD 2.58M 391K 2024-12
Bristol-Myers Squibb USD 496M 9M 2024-12
Canopy Growth CAD 16.77M 4.51M 2024-12
Corcept Therapeutics 6M 6M 2024-06
Eli Lilly USD 224.7M 78.4M 2024-12
J&J USD 137M 56M 2024-12
Knight Therapeutics CAD 1.91M 369K 2024-09
Merck USD 328M 2M 2024-12
Novartis USD 275M 11M 2024-12
Novartis USD 275M 11M 2024-12
Pacira USD 4.68M 9K 2024-12
Pfizer USD 739M 45M 2024-12
Supernus Pharmaceuticals USD 0 0 2024-12
TG Therapeutics USD 10.83M 6.86M 2024-09



Corcept Therapeutics Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.